logo
  

T-Mobile US Q2 Profit Tops Estimates; Revenue Up 13.8% - Quick Facts

T-Mobile US Inc. (TMUS) reported second-quarter net income attributable to common stockholders of $347 million or $0.42 per share, compared to $391 million or $0.48 per share, last year.

The company said the year-over-year decrease in net income and EPS was primarily due to gains on disposal of spectrum licenses of $747 million recognized in the second quarter of 2014, partially offset by a decrease in income tax expense primarily due to the impact of income tax benefits for several discrete items recognized in the second quarter of 2015. Adjusted EBITDA was $1.8 billion, up 25.2% year-over-year.

On average, 22 analysts polled by Thomson Reuters expected the company to report profit per share of $0.18 for the quarter. Analysts' estimates typically exclude special items.

Total revenues were $8.18 billion compared to $7.19 billion, a year ago. Analysts expected revenue of $7.94 billion for the quarter. T-Mobile's total revenues grew by 13.8% year-over-year. The company said the increase was due to continued growth in both service revenues and equipment revenues, which grew by 19.7% year-over-year.

In the second quarter of 2015, T-Mobile added 2.1 million net new customers, including branded postpaid net customer additions of 1.0 million. T-Mobile ended the second quarter of 2015 with 58.9 million total customers.

T-Mobile now expects branded postpaid net customer additions for 2015 to be between 3.4 and 3.9 million, an increase from the previous guidance range of 3.0 to 3.5 million.

T-Mobile expects EPS to be positive for all the remaining quarters and the full-year of 2015. For the full-year of 2015, T-Mobile expects Adjusted EBITDA to be in the range of $6.8 to $7.2 billion, unchanged from previous guidance despite the increase in branded postpaid net customer additions guidance.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT